Following clinical trials showing high effectiveness for inclisiran in treating heart disease, it has now been approved for use by NHS England. The twice yearly injection targets high cholesterol through RNA interference and is expected to prevent early deaths from heart disease and stroke.
New research, published in Nature, points to a complex brain-fat communication circuit that involves immune cells in visceral fat and may help advance our understanding of the links between obesity and chronic inflammation or cancer risk.
According to a study, published in Science, our metabolic rate peaks at first year then remains stable until around 60 years, when decline begins. The study was conducted across 29 countries with 6,400 participants and has generated some unexpected findings.
The English Institute of Sport is launching a study to investigate how hormonal fluctuations during menstruation affect the athletic performance of female athletes, with a view to tailoring training and nutrition to minimise any adverse effects.